Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Inhibition and Stimulation of Intestinal and Hepatic CYP3A Activity: Studies in Humanized CYP3A4 Transgenic Mice Using Triazolam

Robert A. B. van Waterschoot, Rogier W. Rooswinkel, Rolf W. Sparidans, Antonius E. van Herwaarden, Jos H. Beijnen and Alfred H. Schinkel
Drug Metabolism and Disposition December 2009, 37 (12) 2305-2313; DOI: https://doi.org/10.1124/dmd.109.029397
Robert A. B. van Waterschoot
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rogier W. Rooswinkel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rolf W. Sparidans
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonius E. van Herwaarden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jos H. Beijnen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfred H. Schinkel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 37 no. 12 2305-2313
DOI 
https://doi.org/10.1124/dmd.109.029397
PubMed 
19752211

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received July 13, 2009
  • Accepted September 9, 2009
  • Published online November 19, 2009.

Article Versions

  • Earlier version (September 14, 2009 - 10:37).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2009 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Robert A. B. van Waterschoot,
  2. Rogier W. Rooswinkel,
  3. Rolf W. Sparidans,
  4. Antonius E. van Herwaarden,
  5. Jos H. Beijnen and
  6. Alfred H. Schinkel
  1. Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands (R.A.B.v.W., R.W.R., A.E.v.H., A.H.S.); Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands (R.W.S., J.H.B.); and Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands (J.H.B.)
  1. Address correspondence to:
    Alfred H. Schinkel,
    Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
    E-mail: a.schinkel{at}nki.nl
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: September 2009 to April 2021

AbstractFullPdf
Sep 2009900191
Oct 200937087
Nov 200950091
Dec 2009114158
Jan 20102073045
Feb 20101241641
Mar 20101322541
Apr 2010921818
May 2010982024
Jun 2010623719
Jul 201045126
Aug 2010642117
Sep 2010411716
Oct 2010712424
Nov 2010831428
Dec 2010443922
Jan 2011384730
Feb 2011343532
Mar 2011502427
Apr 2011473533
May 2011383343
Jun 2011392432
Jul 2011263133
Aug 2011452932
Sep 2011384231
Oct 2011382827
Nov 2011333039
Dec 2011273332
Jan 2012303527
Feb 2012414140
Mar 2012732535
Apr 2012394627
May 2012382848
Jun 2012282335
Jul 2012332937
Aug 2012262429
Sep 2012332451
Oct 2012362451
Nov 2012371833
Dec 2012282329
Jan 2013533838
Feb 2013344028
Mar 2013491949
Apr 2013293597
May 2013162236
Jun 2013211727
Jul 2013131923
Aug 2013132027
Sep 2013432734
Oct 2013271922
Nov 2013221921
Dec 201310912
Jan 2014301724
Feb 2014131517
Mar 2014181926
Apr 2014181618
May 2014101049
Jun 201471414
Jul 2014111411
Aug 201491410
Sep 20141195
Oct 201417914
Nov 201491017
Dec 2014191311
Jan 2015201612
Feb 201514118
Mar 2015171613
Apr 20151340
May 201581416
Jun 20151494
Jul 2015162318
Aug 201582314
Sep 201571516
Oct 201511811
Nov 2015161110
Dec 20157148
Jan 2016201018
Feb 20168911
Mar 2016231418
Apr 201634216
May 20168812
Jun 2016151518
Jul 201651831
Aug 2016251822
Sep 2016271212
Oct 201615216
Nov 2016101410
Dec 201603117
Jan 201704411
Feb 201712910
Mar 20171419
Apr 20174137
May 201711312
Jun 20170182
Jul 2017192
Aug 20172276
Sep 201713812
Oct 20170399
Nov 201715628
Dec 201702812
Jan 20181268
Feb 201834312
Mar 201833213
Apr 201823412
May 201803712
Jun 20182288
Jul 201801916
Aug 201812511
Sep 201802516
Oct 20180289
Nov 201817916
Dec 201858143
Jan 201985173
Feb 20194785
Mar 20193623
Apr 20193048
May 20194134
Jun 20191926
Jul 20193442
Aug 20193310
Sep 20192356
Oct 20192242
Nov 20193563
Dec 20194364
Jan 20202031
Feb 20201825
Mar 20201722
Apr 20202598
May 20201411
Jun 20202535
Jul 20202301
Aug 20201713
Sep 20201153
Oct 20202424
Nov 20201325
Dec 20203279
Jan 202119125
Feb 202121123
Mar 20212797
Apr 20211746

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 37 (12)
Drug Metabolism and Disposition
Vol. 37, Issue 12
1 Dec 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inhibition and Stimulation of Intestinal and Hepatic CYP3A Activity: Studies in Humanized CYP3A4 Transgenic Mice Using Triazolam
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Inhibition and Stimulation of Intestinal and Hepatic CYP3A Activity: Studies in Humanized CYP3A4 Transgenic Mice Using Triazolam

Robert A. B. van Waterschoot, Rogier W. Rooswinkel, Rolf W. Sparidans, Antonius E. van Herwaarden, Jos H. Beijnen and Alfred H. Schinkel
Drug Metabolism and Disposition December 1, 2009, 37 (12) 2305-2313; DOI: https://doi.org/10.1124/dmd.109.029397

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Inhibition and Stimulation of Intestinal and Hepatic CYP3A Activity: Studies in Humanized CYP3A4 Transgenic Mice Using Triazolam

Robert A. B. van Waterschoot, Rogier W. Rooswinkel, Rolf W. Sparidans, Antonius E. van Herwaarden, Jos H. Beijnen and Alfred H. Schinkel
Drug Metabolism and Disposition December 1, 2009, 37 (12) 2305-2313; DOI: https://doi.org/10.1124/dmd.109.029397
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments.
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Humanized PXR-CAR-CYP3A4/7 Mouse as Model of Induction
  • Ozanimod Human Metabolism and Disposition
  • High-Throughput Characterization of SLCO1B1 VUS
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics